Ciprofloxacin Hydrochloride is a fluoroquinolone antibiotic indicated for urinary tract, respiratory tract, bone and joint, and gastrointestinal infections. We supply it to US manufacturers of tablets, ophthalmic solution and otic solution.
Data from PubChem (CID 62998) and FDA’s substance registry
CAS number
86393-32-0
Molecular formula
C17H21ClFN3O4
Molecular weight
385.8g/mol
FDA UNII
IUPAC name
1-cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic acid;hydrate;hydrochloride
InChIKey
ARPUHYJMCVWYCZ-UHFFFAOYSA-N
- Appearance
- Faintly yellowish to light yellow crystalline substance.
- Solubility
- Sparingly soluble in water, slightly soluble in methanol and very slightly soluble in dehydrated alcohol.
Typical description, from FDA-approved labeling and pharmacopoeial monographs. The specification sent with your quote is the controlling document for any source.
Worth settling with your inquiry
The hydrochloride monohydrate is the salt used in tablets. Injections and oral suspension use ciprofloxacin base, a separate API.
On the US market
- Reference product
- CiproNDA 019537
- Approved ANDAs
- 16 with a marketed product
- Approved forms and strengths
- Tablet 250 mg, 500 mg, 750 mg
- Ophthalmic solution 0.3%
- Otic solution 0.2%
- Ophthalmic ointment 0.3%
Single-ingredient products in FDA’s Drugs@FDA database, retrieved November 2026. Strengths of salt forms are stated as the active moiety. The brand name belongs to its owner and identifies the reference product only.
Grade
USP or Ph. Eur. where a monograph exists, or your own specification.
Quantities
From development quantities for formulation work to commercial supply.
Packaging
To the manufacturer’s standard, typically fiber or HDPE drums with double polyethylene liners.
Regulatory filings
US DMF and CEP availability depends on the source. We confirm the filing status in writing with the quotation.
Documents available with a quote
- Specification and certificate of analysis
- Safety data sheet
- Method of analysis
- DMF letter of authorization, where a US DMF is filed
- GMP certificate and inspection history of the site
- Residual solvents and elemental impurities statements
- Nitrosamine risk assessment
- TSE/BSE statement
Need something else for your QA file? Email info@yogpharma.com